Westfield Capital Management
IRWD icon

Westfield Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Westfield Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-253,491
Closed -$3.14M – 242
2022
Q4 		$3.14M Sell
253,491
-679,278
-73% -$7.71M 0.02% 197
2022
Q3 		$9.66M Sell
932,769
-1,383,359
-60% -$15.7M 0.08% 177
2022
Q2 		$26.7M Sell
2,316,128
-6,218,288
-73% -$73.3M 0.21% 149
2022
Q1 		$107M Buy
8,534,416
+388,742
+5% +$4.46M 0.69% 42
2021
Q4 		$95M Sell
8,145,674
-35,329
-0.4% -$433K 0.56% 57
2021
Q3 		$107M Buy
8,181,003
+1,922,130
+31% +$24.8M 0.64% 43
2021
Q2 		$80.6M Buy
6,258,873
+875,223
+16% +$10M 0.48% 74
2021
Q1 		$60.2M Sell
5,383,650
-3,104,392
-37% -$32.8M 0.37% 96
2020
Q4 		$96.7M Buy
8,488,042
+1,641,850
+24% +$18M 0.57% 59
2020
Q3 		$61.6M Buy
6,846,192
+1,504,988
+28% +$15M 0.4% 83
2020
Q2 		$55.1M Buy
5,341,204
+556,078
+12% +$5.69M 0.38% 90
2020
Q1 		$48.3M Buy
4,785,126
+2,348,030
+96% +$27.6M 0.43% 81
2019
Q4 		$32.4M Sell
2,437,096
-85,393
-3% -$942K 0.23% 133
2019
Q3 		$21.7M Buy
2,522,489
+129,715
+5% +$1.26M 0.17% 148
2019
Q2 		$26.2M Buy
2,392,774
+145,816
+6% +$1.63M 0.2% 152
2019
Q1 		$25.5M Sell
2,246,958
-111,048
-5% -$1.24M 0.19% 157
2018
Q4 		$20.5M Buy
2,358,006
+114,708
+5% +$1.32M 0.17% 155
2018
Q3 		$34.7M Buy
2,243,298
+580,974
+35% +$9.18M 0.24% 136
2018
Q2 		$26.6M Buy
+1,662,324
New +$24.6M 0.2% 156

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Westfield Capital Management's IRWD Position: Q1 2023 in Review

Westfield Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2023, closing a stake of 253,491 shares — an estimated $3.14M sold.

Westfield Capital Management first reported a position in IRWD in Q2 2018 and held it in 19 quarters. The position peaked at $107M in Q1 2022. 254 funds tracked by Wall St. Rank hold IRWD as of Q1 2023.

  • Westfield Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Westfield Capital Management sold 253,491 Ironwood Pharmaceuticals shares in Q1 2023, an estimated $3.14M.
  • Westfield Capital Management first reported a position in Ironwood Pharmaceuticals in Q2 2018 and held it in 19 quarters.
  • Westfield Capital Management's Ironwood Pharmaceuticals position peaked at $107M in Q1 2022.
  • 254 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2023.

Based on Westfield Capital Management's 13F filing for Q1 2023, filed 12 May 2023.